Position in NTLA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,575,078
+$493,608 QoQ
Shares Held
122,861
+2.1% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. NTLA ranks #41 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,575,078 | 122,861 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,081,470 | 120,297 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,779,414 | 103,035 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $599,879 | 63,953 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $388,945 | 54,704 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $630,118 | 54,041 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,163,027 | 56,595 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,282,955 | 57,326 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,419,268 | 51,591 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,418,882 | 46,536 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,416,512 | 44,798 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,817,931 | 44,579 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,437,913 | 38,581 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,255,725 | 35,991 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,225,361 | 39,767 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,164,758 | 41,823 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,973,002 | 40,911 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,278,588 | 44,643 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,869,330 | 43,752 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,789,695 | 41,935 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,314,589 | 53,761 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,355,900 | 43,307 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $613,238 | 30,847 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $555,789 | 26,441 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $147,151 | 12,032 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||